David L. Mahoney

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cupertino, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for David L Mahoney
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for David L. Mahoney

Form 4 holding Director

CORCEPT THERAPEUTICS INC

Security class
Common Stock
Shares / value
1,133,539
Estimated value
$135,614,452
Report date
18 Aug 2026
Price
$119.64
Ownership
Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust
Form 4 holding Director

Adamas Pharmaceuticals Inc

Security class
Common Stock
Shares / value
0
Estimated value
Report date
24 Nov 2021
Price
$5.16
Ownership
David L. Mahoney & Winnifred C. Ellis 1998 Family Trust
Form 4 holding Director

Adamas Pharmaceuticals Inc

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
24 Nov 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by David L. Mahoney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .